132 related articles for article (PubMed ID: 29599309)
1. MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
Santoro R; Zanotto M; Carbone C; Piro G; Tortora G; Melisi D
Anticancer Res; 2018 Apr; 38(4):1937-1946. PubMed ID: 29599309
[TBL] [Abstract][Full Text] [Related]
2. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
3. Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.
Santoro R; Zanotto M; Simionato F; Zecchetto C; Merz V; Cavallini C; Piro G; Sabbadini F; Boschi F; Scarpa A; Melisi D
Mol Cancer Ther; 2020 Jan; 19(1):247-257. PubMed ID: 31562256
[TBL] [Abstract][Full Text] [Related]
4. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3.
Yang S; Zhang L; Purohit V; Shukla SK; Chen X; Yu F; Fu K; Chen Y; Solheim J; Singh PK; Song W; Dong J
Oncotarget; 2015 Nov; 6(34):36019-31. PubMed ID: 26440309
[TBL] [Abstract][Full Text] [Related]
5. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
6. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition.
Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G
J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433
[TBL] [Abstract][Full Text] [Related]
7. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
Chai TF; Manu KA; Casey PJ; Wang M
Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852
[TBL] [Abstract][Full Text] [Related]
8. YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.
Pan Z; Tian Y; Zhang B; Zhang X; Shi H; Liang Z; Wu P; Li R; You B; Yang L; Mao F; Qian H; Xu W
Int J Oncol; 2017 Oct; 51(4):1055-1066. PubMed ID: 28848999
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
[TBL] [Abstract][Full Text] [Related]
10. YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice.
Park J; Eisenbarth D; Choi W; Kim H; Choi C; Lee D; Lim DS
Cancer Res; 2020 Nov; 80(21):4768-4779. PubMed ID: 32900774
[TBL] [Abstract][Full Text] [Related]
11. Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.
Gopal U; Mowery Y; Young K; Pizzo SV
J Biol Chem; 2019 Sep; 294(38):13939-13952. PubMed ID: 31358620
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
Liu Z; Hayashi H; Matsumura K; Ogata Y; Sato H; Shiraishi Y; Uemura N; Miyata T; Higashi T; Nakagawa S; Mima K; Imai K; Baba H
Br J Cancer; 2023 Mar; 128(5):844-856. PubMed ID: 36536047
[TBL] [Abstract][Full Text] [Related]
13. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.
Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z
Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921
[TBL] [Abstract][Full Text] [Related]
14. The role of YAP/TAZ activity in cancer metabolic reprogramming.
Zhang X; Zhao H; Li Y; Xia D; Yang L; Ma Y; Li H
Mol Cancer; 2018 Sep; 17(1):134. PubMed ID: 30176928
[TBL] [Abstract][Full Text] [Related]
15. TAZ
Yao CB; Zhang M; Zhou X; Lei QY; Yin M
Biochem Biophys Res Commun; 2018 Sep; 503(4):2240-2247. PubMed ID: 29953851
[TBL] [Abstract][Full Text] [Related]
16. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
[No Abstract] [Full Text] [Related]
17. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
Ishihara E; Nishina H
Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
[TBL] [Abstract][Full Text] [Related]
18. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
[TBL] [Abstract][Full Text] [Related]
20. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors.
Hagenbeek TJ; Webster JD; Kljavin NM; Chang MT; Pham T; Lee HJ; Klijn C; Cai AG; Totpal K; Ravishankar B; Yang N; Lee DH; Walsh KB; Hatzivassiliou G; de la Cruz CC; Gould SE; Wu X; Lee WP; Yang S; Zhang Z; Gu Q; Ji Q; Jackson EL; Lim DS; Dey A
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
